The MassBio Investors Forum provides a unique opportunity for innovative biotechnology companies to find investors and partners, and for global health care companies to enhance their pipeline through global partnerships.

The 2010 MassBio Investors Forum will be held in conjunction with BioPharm America 2010. For more information and to register, please visit http://www.ebdgroup.com/bpa/. Read a press release announcing the partnership online.

Regionally, MassBio's Investors Forum is New England's largest biotechnology investor forum. With keynote presentations and roundtable discussions, this event brings together key members of the biotech ecosystem for discussion and debate around plans for successful financing using a mix of traditional and alternative financing mechanisms.

Participants include representatives from venture capital, institutional and private equity investor communities; top level industry executives in business development, corporate development and strategic alliances; biotech and pharmaceutical executives; health care leaders; academic leaders; and representatives from disease foundations and government organizations offering financing opportunities.

Held at the historic Omni Parker House, just steps away from Beacon Hill, our annual Policy Leadership Breakfast brings industry leaders together with Massachusetts public policy leaders for keynote presentations and panel discussions designed to educate and promote an open dialogue.    This event is a must-attend for senior industry leaders, policy makers and staff, and pharma and biotech government affairs executives.

The MassBio Annual Meeting focuses on the most timely and critical challenges facing the Massachusetts biotechnology industry.  The meeting program is pulled together by a Steering Committee of leaders in the industry and the agenda encompasses keynote presentations, panel discussions, interactive working sessions, and extensive networking opportunities for all MassBio members.

Listen to comments from Mike Bonney, this year's Innovative Leadership Award winner who was honored at the 2010 MassBio Annual Meeting.

As one of MassBio's new partnering programs, Pharma Days are designed to maximize buyer and seller interactions and to prospect for pipeline growth.  Pharma Days aggregate over 120 biotechnology companies in one place at one time, bringing buyers and sellers together for in person conversations. This highly efficient forum reduces meeting set-up inefficiencies, and provides an intimate opportunity for pharma to meet prospectively with new emerging biotechnology companies.

MassBio can help pharma companies speak to biotech companies "under the radar," and arrange the right meeting with the right people for the right indications, specific to an organization's pipeline.

For buyers, Pharma Days comprises a one to two day unique partnering event that is all about your company and the visibility you get before 120+ of the most innovative biotechnology firms;

• One-on-one partnering with CEOs and heads of business development in your therapeutic/diagnostic space.
• Present your company’s sourcing strategy for new licenses and acquisitions to the biotechnology community.
• Intimate and unhurried exchange of information.
• Obviate the frenzy and “noise” of other major partnering conferences

MassBio staff will work with you to:

• identify, invite and follow up with the contacts you’d like to meet.
• A one to two day unique partnering event that is all about your company and the visibility you get before 120+ of the most innovative biotechnology firms;

Check out the Boston Business Journal's story on Pharma Days.

If you or your organization is interested in partnering on a 2010 Pharma Day, please contact Imran Nasrullah at imran.nasrullah@massbio.org or 617-674-5100.

The new Innovators' Roundtable series feature one day, high impact, invite only roundtable discussion of leading scientific, clinical and business leaders in a specific therapeutic space (metabolic, oncology, CNS, inflammatory disease) convened to address disease - from innovation to commercialization - in a challenging funding environment.

The Massachusetts life sciences super cluster represents one of the global centers of excellence for healthcare innovation and entrepreneurship. Yet market forces may ignore commercialization of necessary innovation to meet unmet medical needs. Although new players and models for funding are emerging, new thinking is required (especially in the current economic climate) and must involve all stakeholders across the healthcare value chain, from patient advocates to entrepreneurs to big pharma.

The focus of Innovators' Roundtables is to identify critical early stage innovations that need to be assured funding to secure the flow of innovations longer-term. MassBio is bringing together disease foundations, academia, venture, biotechnology and pharmaceutical companies to address how key stakeholders across the healthcare value chain can create an integrated view towards new venture creation, product development, commercialization and, ultimately, delivery of healthcare in specific therapeutic areas.

Play 18 holes on a beautiful course - then add food, drinks, networking, and fun - all for an excellent cause. The annual MassBioEd Foundation's Golf Classic supports the foundation's activities in science and biotechnology education in Massachusetts through school programs, workforce training, and lifelong learning.

MassBioEd's BioTeach program strives to provide every public high school in Massachusetts with the skills and tools that are necessary to teach biotechnology. Since 2005, BioTeach has engaged high school students with hands-on lab experiences that inspire scientific curiosity, understanding, and for many students, a career in the life sciences. To date, 179 schools have participated in the BioTeach program. MassBioEd has awarded more than $2 million in grants for lab supplies in high school classrooms across the Commonwealth.

Other MassBioEd initiatives include the Biotechnology Learning Center, which focuses on strengthening the biotech workforce and educating the community in general through continuing education courses, seminars, online resources and certificate programs.

Visit the MassBioEd website.

Alnylam, Genzyme, BiogenIdec, Boston Scientific, Sirtris, Confluent Surgical. These are just a few of the multimillion dollar commercial life sciences ventures that have grown in Massachusetts based on innovative research undertaken in the Commonwealth.  Each started as a compelling idea and a few committed researchers and now improve the health of millions every year.  Massachusetts Life Sciences Innovation Day is a one-of-a-kind event. It is a celebration of the achievements of some of the most creative and brilliant minds in Massachusetts, as well as an opportunity to inspire, educate and connect people in the innovation and entrepreneurial ecosystem. 

To learn more, visit the MALSI Day homepage.

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Michael J. Fox, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The convention also includes hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition - the BIO Exhibition.

To learn more, visit the convention website.

Learn how to maximize your MassBio membership:

• Make sure you are taking advantage of our Purchasing Consortium
• Learn more about MassBio Committees and Signature Events
• Connect with our Economic Development and Public Policy services
• Network with other MassBio members
• Talk one-on-one with the MassBio team to get your questions or concerns addressed